Drug Type Small molecule drug |
Synonyms dual mTORC1/AMPK agonist (NovoMedix) |
Target |
Action inhibitors |
Mechanism AMPK inhibitors(AMP activated protein kinase inhibitors), mTORC1 inhibitors(Mammalian target of Rapamycin (mTORC1) inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic breast cancer | Preclinical | United States | - |